Taysha Gene Therapies, Inc. (TSHA)

5.49 -0.05 (-0.90%) USD  |  NASDAQ  |  May 22, 16:00
5.49 0.00 (0.00%) After-Hours: 20:00
More

Taysha Gene Therapies EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for TSHA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
BioCryst Pharmaceuticals, Inc. Upgrade
United Therapeutics Corp. Upgrade
TG Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
UroGen Pharma Ltd. Upgrade